Skip to main content

hydrocortisone MR (Efmody®)

 

Appraisal in progress

Indication

Status: In progress

Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.

Medicine details

Medicine name hydrocortisone MR (Efmody®)
Formulation 5 mg, 10 mg, 20 mg modified-release hard capsules
Reference number 3017
Indication

As above

Company Diurnal Limited
BNF chapter Endocrine system
Submission type Full
Status In progress
NMG meeting date TBC
AWMSG meeting date TBC
Date of issue TBC
Follow AWTTC: